Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 104
Published Date: 01 Apr 2022
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags
Description
The Gamma-aminobutyric Acid (GABA) Receptor Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gamma-aminobutyric Acid (GABA) Receptor Agonist market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Gamma-aminobutyric Acid (GABA) Receptor Agonist global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gamma-aminobutyric Acid (GABA) Receptor Agonist include Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, and Aytu BioScience, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gamma-aminobutyric Acid (GABA) Receptor Agonist market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Parenteral
Intrathecal
Others
Market segment by Application, can be divided into
Hospitals
Specialty Clinics
Others
Market segment by players, this report covers
Sanofi
Mylan N.V.
Teva Pharmaceutical Industries
Novartis
Aytu BioScience
Dr. Reddy’s Laboratories
Endo Pharmaceuticals
Lupin
Johnson & Johnson Services
Lannett
Sun Pharmaceutical Industries
Cipla
Aurobindo Pharma
Zydus Cadila
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gamma-aminobutyric Acid (GABA) Receptor Agonist product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gamma-aminobutyric Acid (GABA) Receptor Agonist, with revenue, gross margin and global market share of Gamma-aminobutyric Acid (GABA) Receptor Agonist from 2019 to 2022.
Chapter 3, the Gamma-aminobutyric Acid (GABA) Receptor Agonist competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gamma-aminobutyric Acid (GABA) Receptor Agonist market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gamma-aminobutyric Acid (GABA) Receptor Agonist research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gamma-aminobutyric Acid (GABA) Receptor Agonist
1.2 Classification of Gamma-aminobutyric Acid (GABA) Receptor Agonist by Type
1.2.1 Overview: Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Type in 2021
1.2.3 Oral
1.2.4 Parenteral
1.2.5 Intrathecal
1.2.6 Others
1.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market by Application
1.3.1 Overview: Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size & Forecast
1.5 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast by Region
1.5.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region, (2017-2022)
1.5.3 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Prospect (2017-2028)
1.5.4 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Prospect (2017-2028)
1.5.6 South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers
1.6.2 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
1.6.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Trends Analysis
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.1.4 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Mylan N.V.
2.2.1 Mylan N.V. Details
2.2.2 Mylan N.V. Major Business
2.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.2.4 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Mylan N.V. Recent Developments and Future Plans
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.3.4 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.4.4 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Aytu BioScience
2.5.1 Aytu BioScience Details
2.5.2 Aytu BioScience Major Business
2.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.5.4 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Aytu BioScience Recent Developments and Future Plans
2.6 Dr. Reddy’s Laboratories
2.6.1 Dr. Reddy’s Laboratories Details
2.6.2 Dr. Reddy’s Laboratories Major Business
2.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.6.4 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans
2.7 Endo Pharmaceuticals
2.7.1 Endo Pharmaceuticals Details
2.7.2 Endo Pharmaceuticals Major Business
2.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.7.4 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.8 Lupin
2.8.1 Lupin Details
2.8.2 Lupin Major Business
2.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.8.4 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Lupin Recent Developments and Future Plans
2.9 Johnson & Johnson Services
2.9.1 Johnson & Johnson Services Details
2.9.2 Johnson & Johnson Services Major Business
2.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.9.4 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Johnson & Johnson Services Recent Developments and Future Plans
2.10 Lannett
2.10.1 Lannett Details
2.10.2 Lannett Major Business
2.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.10.4 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Lannett Recent Developments and Future Plans
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.11.4 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
2.12 Cipla
2.12.1 Cipla Details
2.12.2 Cipla Major Business
2.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.12.4 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Cipla Recent Developments and Future Plans
2.13 Aurobindo Pharma
2.13.1 Aurobindo Pharma Details
2.13.2 Aurobindo Pharma Major Business
2.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.13.4 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Aurobindo Pharma Recent Developments and Future Plans
2.14 Zydus Cadila
2.14.1 Zydus Cadila Details
2.14.2 Zydus Cadila Major Business
2.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
2.14.4 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Zydus Cadila Recent Developments and Future Plans
3.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Players Market Share in 2021
3.2.2 Top 10 Gamma-aminobutyric Acid (GABA) Receptor Agonist Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Players Head Office, Products and Services Provided
3.4 Gamma-aminobutyric Acid (GABA) Receptor Agonist Mergers & Acquisitions
3.5 Gamma-aminobutyric Acid (GABA) Receptor Agonist New Entrants and Expansion Plans
4.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Market Share by Type (2017-2022)
4.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast by Type (2023-2028)
5.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Application (2017-2022)
5.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Forecast by Application (2023-2028)
6.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2028)
6.2 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2028)
6.3 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
6.3.1 North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2028)
6.3.2 United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
6.3.3 Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
6.3.4 Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
7.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2028)
7.2 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2028)
7.3 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
7.3.1 Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2028)
7.3.2 Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
7.3.3 France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
7.3.5 Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
7.3.6 Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
8.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2028)
8.2 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2028)
8.3 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Region
8.3.1 Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Region (2017-2028)
8.3.2 China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
8.3.3 Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
8.3.4 South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
8.3.5 India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
8.3.7 Australia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
9.1 South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2028)
9.2 South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2028)
9.3 South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
9.3.1 South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2028)
9.3.2 Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
9.3.3 Argentina Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
10.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2028)
10.2 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2028)
10.3 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size by Country
10.3.1 Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2028)
10.3.2 Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
10.3.4 UAE Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size and Forecast (2017-2028)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Region (2023-2028)
Table 6. Sanofi Corporate Information, Head Office, and Major Competitors
Table 7. Sanofi Major Business
Table 8. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 9. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Mylan N.V. Corporate Information, Head Office, and Major Competitors
Table 11. Mylan N.V. Major Business
Table 12. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 13. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 15. Teva Pharmaceutical Industries Major Business
Table 16. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 17. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 21. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Aytu BioScience Corporate Information, Head Office, and Major Competitors
Table 23. Aytu BioScience Major Business
Table 24. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 25. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Dr. Reddy’s Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Dr. Reddy’s Laboratories Major Business
Table 28. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 29. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Endo Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Endo Pharmaceuticals Major Business
Table 32. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 33. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Lupin Corporate Information, Head Office, and Major Competitors
Table 35. Lupin Major Business
Table 36. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 37. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Johnson & Johnson Services Corporate Information, Head Office, and Major Competitors
Table 39. Johnson & Johnson Services Major Business
Table 40. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 41. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Lannett Corporate Information, Head Office, and Major Competitors
Table 43. Lannett Major Business
Table 44. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 45. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sun Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 47. Sun Pharmaceutical Industries Major Business
Table 48. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 49. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Cipla Corporate Information, Head Office, and Major Competitors
Table 51. Cipla Major Business
Table 52. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 53. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Aurobindo Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Aurobindo Pharma Major Business
Table 56. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 57. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 59. Zydus Cadila Major Business
Table 60. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Product and Solutions
Table 61. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Gamma-aminobutyric Acid (GABA) Receptor Agonist by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Gamma-aminobutyric Acid (GABA) Receptor Agonist Players Head Office, Products and Services Provided
Table 66. Gamma-aminobutyric Acid (GABA) Receptor Agonist Mergers & Acquisitions in the Past Five Years
Table 67. Gamma-aminobutyric Acid (GABA) Receptor Agonist New Entrants and Expansion Plans
Table 68. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) by Type (2017-2022)
Table 69. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Share by Type (2017-2022)
Table 70. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Forecast by Type (2023-2028)
Table 71. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2022)
Table 72. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Forecast by Application (2023-2028)
Table 73. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Picture
Figure 2. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Parenteral
Figure 5. Intrathecal
Figure 6. Others
Figure 7. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Specialty Clinics Picture
Figure 10. Others Picture
Figure 11. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 14. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Region in 2021
Figure 15. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers
Figure 21. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints
Figure 22. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. Mylan N.V. Recent Developments and Future Plans
Figure 25. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Aytu BioScience Recent Developments and Future Plans
Figure 28. Dr. Reddy’s Laboratories Recent Developments and Future Plans
Figure 29. Endo Pharmaceuticals Recent Developments and Future Plans
Figure 30. Lupin Recent Developments and Future Plans
Figure 31. Johnson & Johnson Services Recent Developments and Future Plans
Figure 32. Lannett Recent Developments and Future Plans
Figure 33. Sun Pharmaceutical Industries Recent Developments and Future Plans
Figure 34. Cipla Recent Developments and Future Plans
Figure 35. Aurobindo Pharma Recent Developments and Future Plans
Figure 36. Zydus Cadila Recent Developments and Future Plans
Figure 37. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Share by Players in 2021
Figure 38. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share in 2021
Figure 40. Global Top 10 Players Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Share by Type in 2021
Figure 43. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share Forecast by Type (2023-2028)
Figure 44. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Share by Application in 2021
Figure 45. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Share Forecast by Application (2023-2028)
Figure 46. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 47. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 48. North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 49. United States Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 53. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 54. Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 55. Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Region (2017-2028)
Figure 63. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 70. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 71. South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi Mylan N.V. Teva Pharmaceutical Industries Novartis Aytu BioScience Dr. Reddy’s Laboratories Endo Pharmaceuticals Lupin Johnson & Johnson Services Lannett Sun Pharmaceutical Industries Cipla Aurobindo Pharma Zydus Cadila
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
